The aim of this article is to identify the elements behind the country’s successful COVID-19 rollout as well as lessons and chal lenges derived from this process. The analysis is relevant to many countries today—as they keep searching for strategies to cope with the second year of the COVID-19 p...andemic and the challenge of implementing a large-scale vaccine rollout—and in the coming years—as new variants develop and unceertainty about the vaccination strategy increases.
more
CONVIDECIA is based on a modified human adenovirus that expresses the spike S protein of SARS-CoV-2. It is administered as a single dose.
The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards the Immunization Agenda 2030 and pandemic prevention, preparedn...ess and response efforts. The report is organized in two sections: the first section provides WHO insights on global vaccine market dynamics, drawing from data provided by Member States, which are, in turn, analysed and displayed in the second section.
more
A lack of knowledge about the threat of vaccine-preventable diseases, risks and benefits of vaccines, mistrust of government and health workers, poor service delivery and alternative health or relig...ious beliefs play a role in lower uptake of some vaccines. These challenges underscore the importance of early integration and investment in a thoughtful communication plan for immunization programmes. This World Health Organization (WHO) report presents communication guidance and specific considerations for countries that plan to introduce human papillomavirus (HPV) vaccine into their national immunisation programme as part of an effort to prevent cervical cancer.
more
Disease outbreak news 30 October 2018
Weekly epidemiological recordRelevé épidémiologique hebdomadaire 29 JULY 2016, 91th YEAR / 29 JUILLET 2016, 91e ANNÉENo 30, 2016, 91, 349–364
YouTube influencer Healthcare Triage talked with WHO's Dr Kate O'Brien about how the COVID-19 vaccine works, how it gets distributed, and how we distribute it equitably.
1:27 Safety questions and concerns about quick development of the ..."attribute-to-highlight medbox">vaccine.
7:18 Have we entered a new age where all vaccines will be developed this easily and quickly?
8:41 Questions about vaccine distribution – how’s it gonna work?
10:36 How do we make sure we distribute the vaccine equitably?
11:59 How do we make sure all countries get the same seat at the vaccine table?
13:29 What are reasonable expectations about the vaccine and life returning to “normal”?
15:14 Misinformation about the vaccine
17:00 Specific myths about the vaccine
18:18 The bigger picture – what have we learned from this pandemic that we should apply in the future?
more
The objectives of pertussis surveillance are to:hmonitor disease burden and the impact of the pertussis vaccination programme, with a special focus on understanding the morbidity and mortality in children < 5 years of agehgenerate data to inform ...an class="attribute-to-highlight medbox">vaccine schedule and delivery strategy decisions to optimize the impact of vaccinationhdetect and guide public health response to outbreaks of pertussis
more
The Vaccination Demand Hub is a network of partner organizations innovating together to understand why people miss out and to improve acceptance and uptake of vaccines, to ensure that everyone every...where is protected against vaccine preventable diseases.
more
Vaksen MMRV (Lawoujòl, Malmouton,
Ribeyòl, ak Varisèl): Sa Ou Dwe Konnen
Vaksen Kont Polyo
Ki Sa Ou Bezwen Konnen